NCT00002980View on ClinicalTrials.gov

Decitabine in Treating Patients With Melanoma or Other Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 1997

Conditions
Chronic Myeloproliferative DisordersLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesPrecancerous ConditionUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

decitabine

Trial Locations (4)

90033

Los Angeles County-University of Southern California Medical Center, Los Angeles

91010

Beckman Research Institute, City of Hope, Duarte

95817

University of California Davis Cancer Center, Sacramento

90033-0800

USC/Norris Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

California Cancer Consortium

NETWORK